2,3,4,9-Tetrahydro-1,2-dimethyl-1H-pyrido[3,4-b]indole(27297-47-8)
- Name: 2,3,4,9-Tetrahydro-1,2-dimethyl-1H-pyrido[3,4-b]indole
- Synonyms:Leptocladine(7CI,8CI); N-Methylcalligonine; NSC 96916; Nb-Methyltetrahydroharman
- Molecular Formula:C13H16 N2
- Molecular Weight:200.283
- CAS Registry Number:27297-47-8
- EINECS:
- Melting Point:109-11O°C
- Water Solubility:
CAS No.27297-47-8 1H-Pyrido[3,4-b]indole,2,3,4,9-tetrahydro-1,2-dimethyl- (9CI)
Assay:90%,98% Appearance:detailed see specifications Package:according to the clients requirement Storage:Store in dry, dark and ventilated place. Transportation:by air or by sea Application:Used in Synthesis, Pharmaceuticals and other fields
Min. Order:1Kilogram
Supplier:Dayang Chem (Hangzhou) Co.,Ltd. [
China (Mainland)]
CAS No.27297-47-8 27297-47-8
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)]
CAS No.27297-47-8 1H-Pyrido[3,4-b]indole,2,3,4,9-tetrahydro-1,2-dimethyl- (9CI)
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]

Other Product
- 51028-92-3/5-Methoxy-4'-methyl-3-biphenylacetic acid
- 9086-52-6/Poly(oxy-1,2-ethanediyl), .alpha.-bis(1-phenylethyl)phenyl-.omega.-hydroxy-
- 22258-75-9/2-(1,3-benzothiazol-2-ylsulfanyl)ethanamine
- 12001-68-2/Borate(2-), bis[m-[(2R,3R)-2,3-di(hydroxy-kO)butanedioato(4-)-kO1:kO4]]di-, dipotassium (9CI)
- 1439-06-1/Oxirane, 2,3-dipropyl-,(2R,3S)-rel-
- 219691-53-9/9,3a-(Epoxymethano)-3aH-cyclopropa[3,4]benz- [1,2-f]azulene-3,4,5,7a,8,11(4H)-hexol,dodecahydro-1,1,6,9-tetramethyl-,(1aS,3R,- 3aR,4R,4aR,5S,6S,7aR,8S,9R,9aR,9bS,11R)-
- 19154-48-4/Carbonic acid,compounds,magnesium potassium salt (2:1:1),tetrahydrate
- 90605-13-3/Phosphoric acid, 2-methylpropyl ester, potassium salt
- 87471-33-8/4-demethoxy-4'-O-methyldoxorubicin
- 54993-23-6/(3beta)-20,22-epoxycholest-5-en-3-ol
- 4425-33-6/[4,4'-Bipyridine]-3,3'-dicarboxamide
- 113849-16-4/(5Z,8Z)-9-(4-chlorophenyl)-7,7-dimethylnona-5,8-dienoic acid
- 68937-83-7/Fatty acids, C6-10 methyl esters
- 85895-76-7/Pentanedial, reaction products with formaldehyde and glyoxal
- 77493-04-0/2-(1,2,4-benzotriazin-3-yl)acetamide
- 104701-05-5/2-(1,3-Benzodioxol-5-yl)-3,3a,4,7-tetrahydro-5,7-dimethoxy-3-methyl-3a-(2-propenyl)benzofuran-7a(2H)-ol
- 104132-99-2/Ferrate(2-), [N,N-bis[2-[bis(carboxymethyl) amino]ethyl]glycinato(5-)]-, ammonium
- 6298-41-5/9,10-dioxo-8-(phenylamino)-5-[(4-sulfophenyl)amino]-9,10-dihydroanthracene-2-sulfonic acid
- 58439-41-1/Nickel alloy,base,Ni 39-41,Co 19-21,Cr 19-21,Fe 0-8.7,Mo 7.5-8.5,Ti 2.8-3.2,Cu 1.8-2.2,Al 1.4-1.8,Mn 0.8-1.2,Si 0-0.5 (40NKKhTYuMD)
- 27297-47-8/2,3,4,9-Tetrahydro-1,2-dimethyl-1H-pyrido[3,4-b]indole
- 6048-81-3/Silane,1-propenylidenebis[methyl-
- 66941-09-1/1,5-Dimethyl-5-(1-methylbutyl)-2-sodiothio-4,6(1H,5H)-pyrimidinedione
- 76283-90-4/4-[(4-methylphenyl)sulfonyl]-4-nitro-1,7-diphenylheptane-1,7-dione
- 88570-82-5/Imidazo(1,2-a)pyridine-3-acetamide, 2-(5-bromo-2-furanyl)-N,N,6-trimethyl-
- 91567-72-5/N-[4-(diethenylsulfamoyl)phenyl]acetamide
- 22007-56-3/1,2-octanediyl diacetate
- 149998-44-7/2(1H)-Quinolinone,3-[[(2R,3S)-3-(hydroxymethyl)-3-methyloxiranyl]methyl]-4,8-dimethoxy-1-methyl-,rel- (9CI)
- 27957-04-6/4,11[3',4']-Furanocyclooct[f]isobenzofuran-1,3,13,15-tetrone,3a,4,11,11a,12,16-hexahydro-
- 194353-46-3/(1S,2R,5R)-5-(6-amino-9H-purin-9-yl)-3-[(1R)-1-hydroxyprop-2-yn-1-yl]cyclopent-3-ene-1,2-diol
- 4664-67-9/(1-chlorocyclohexyl)[4-(dimethylamino)phenyl]methanone